2-(2-Chloroquinazolin-4-yl)-9-phenyl-9H-carbazole

Catalog No. :
ACGFJQ746
CAS No. :
1616499-37-6
Molecular Formula :
C26H16ClN3
Molecular Weight :
405.89

IUPAC Name:2-(2-chloroquinazolin-4-yl)-9-phenyl-9H-carbazole

2-(2-Chloroquinazolin-4-yl)-9-phenyl-9H-carbazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$108.00Login to see priceIn stockInquiry
25g97%$342.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Chloroquinazolin-4-yl)-9-phenyl-9H-carbazole
IUPAC Name2-(2-chloroquinazolin-4-yl)-9-phenyl-9H-carbazole
MDL No.MFCD30187278
Molecular FormulaC26H16ClN3
Molecular Weight405.89
SMILESClC1=NC(C2=CC(N(C3=CC=CC=C3)C4=C5C=CC=C4)=C5C=C2)=C6C=CC=CC6=N1
InChI KeyXCNYSGLGEPGIPV-UHFFFAOYSA-N
Synonym2-(2-chloro-4-quinazolinyl)-9-phenyl-9H-Carbazole;2-(2-Chloroquinazolin-4-yl)-9-phenyl-9H-carbazole;2-(2-Chloro-4-quinazolinyl)-N-phenylcarbazole;9H-Carbazole, 2-(2-chloro-4-quinazolinyl)-9-phenyl-;2-(2-Chloro-4-quinazolinyl)-N-phenyl- 9H-carbazole
CAS No.1616499-37-6
PubChem CID90269802

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACGFJQ746 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQEKC689 route compound structure diagram
    ACQEKC689607-68-1 In Stock
  2. Plus
  3. ACOURI853 route compound structure diagram
    ACOURI8531001911-63-2 In Stock
  4. Then
  5. ACGFJQ746 route product structure diagram
    ACGFJQ7461616499-37-6 In Stock
Inquiry

2. ACGFJQ746 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGFJQ746 route product structure diagram
    ACGFJQ7461616499-37-6 In Stock
Inquiry

Comments (0)